![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: BRCA1 & 2
October 3, 2018
Science In 60: Looking Beyond BRCA 1/2 to Identify Women at Risk for Breast Cancer
Science In 60: Looking Beyond BRCA 1/ 2 to Identify Women at Risk for Breast Cancer
BRCA1 & 2
Breast Cancer
Science in 60
Screening
April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
HBOC
Mayo Clinic
NCCN
PALB2
RAD51D
March 2, 2017
RNA Labs—How they Impact the Medical World
By having the ATG Lab at Ambry, it is possible to further refine VUS results and look beyond DNA in order to determine the benign…
BRCA1 & 2
Genetic Testing
Variant of Unknown Significance
VUS
December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Ambry Genetics, Huntsman Cancer Institute and Mayo Clinic conduct largest reported study of men with breast cancer undergoing multi-gene panel testing.
BRCA1 & 2
CHEK2
Huntsman Cancer Institute
Male Breast Cancer
Mayo Clinic
PALB2
December 18, 2016
Congratulations to the 2016 Battle for the Breasts Winners!
The Mauli Ola Foundation has announced the winning team of their 3rd annual Battle for the Breasts (B4TB) online surf contest, as of the end of October,…
Battle for the Breasts
BRCA1 & 2
Breast Cancer
Breast Cancer Awareness
Mauli Ola Foundation
December 14, 2016
Dr. Fergus Couch Talks with Ambry about Recent Study Findings
Mayo Clinic Researcher Dr. Fergus Couch talks with Ambry about recent findings from the largest hereditary breast cancer patient study to date.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
Mayo Clinic
RAD51D
